Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases – a meta-analysis

Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387

van der Geest, 2015, Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases, Clin Exp Metastasis, 32, 457, 10.1007/s10585-015-9719-0

Hugen, 2014, Metastatic pattern in colorectal cancer is strongly influenced by histological subtype, Ann Oncol Off J Eur Soc Med Oncol, 25, 651, 10.1093/annonc/mdt591

Elferink, 2015, Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands, Int J Colorectal Dis, 30, 205, 10.1007/s00384-014-2085-6

Benson, 2007, Epidemiology, disease progression, and economic burden of colorectal cancer, J Manag Care Pharm, 13, S5, 10.18553/jmcp.2007.13.s6-c.5

Ayez, 2013, Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score, Dig Surg, 30, 451, 10.1159/000357351

Clancy, 2014, A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival, Ann Surg Oncol, 21, 3900, 10.1245/s10434-014-3805-4

Folprecht, 2010, Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial, Lancet Oncol, 11, 38, 10.1016/S1470-2045(09)70330-4

Fusai, 2003, Strategies to increase the resectability of liver metastases from colorectal cancer, Dig Surg, 20, 481, 10.1159/000073535

Adam, 2007, Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases, Surg Oncol Clin N Am, 16, 525, 10.1016/j.soc.2007.04.016

van Lienden, 2013, Portal vein embolization before liver resection: a systematic review, Cardiovasc Interv Radiol, 36, 25, 10.1007/s00270-012-0440-y

Nosher, 2015, Non-operative therapies for colorectal liver metastases, J Gastrointest Oncol, 6, 224

Kageyama, 2013, Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors, Cardiovasc Interv Radiol, 36, 1383, 10.1007/s00270-013-0650-y

Vanagas, 2010, Radiofrequency ablation of liver tumors (I): biological background, Medicina (Kaunas), 46, 13, 10.3390/medicina46010002

Wong, 2010, American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer, J Clin Oncol Off J Am Soc Clin Oncol, 28, 493, 10.1200/JCO.2009.23.4450

Weng, 2012, Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis, PLoS One, 7, e45493, 10.1371/journal.pone.0045493

Wu, 2011, Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis, World J Gastroenterol, 17, 4143, 10.3748/wjg.v17.i36.4143

Cirocchi, 2012, Radiofrequency ablation in the treatment of liver metastases from colorectal cancer, Cochrane Database Syst Rev, 6

Han, 2016, Radiofrequency ablation versus liver resection for colorectal cancer liver metastasis: an updated systematic review and meta-analysis, Chin Med J, 129, 2983, 10.4103/0366-6999.195470

Hompes, 2011, Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin, Cancer Imaging Off Publ Int Cancer Imaging Soc, 11, 23

van Amerongen, 2016, Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, 42, 523

Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

Abdalla, 2004, Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases, Ann Surg, 239, 818, 10.1097/01.sla.0000128305.90650.71

Agcaoglu, 2013, Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients, World J Surg, 37, 1333, 10.1007/s00268-013-1981-1

Aliyev, 2013, Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis, Surgery, 154, 556, 10.1016/j.surg.2013.03.009

Aloia, 2006, Solitary colorectal liver metastasis: resection determines outcome, Arch Surg, 141, 460, 10.1001/archsurg.141.5.460

Berber, 2008, Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis, J Gastrointest Surg Off J Soc Surg Aliment Tract, 12, 1967, 10.1007/s11605-008-0622-8

Curley, 2005, Outcomes after surgical treatment of colorectal cancer liver metastases, Semin Oncol, 32, S109, 10.1053/j.seminoncol.2005.06.011

Gleisner, 2008, Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation, Arch Surg, 143, 1204, 10.1001/archsurg.143.12.1204

Hur, 2009, Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases, Am J Surg, 197, 728, 10.1016/j.amjsurg.2008.04.013

Jasarovic, 2014, Resection or radiofrequency ablation of colorectal liver metastasis, Vojnosanitet Pregled Mil Med Pharm Rev, 71, 542, 10.2298/VSP1406542J

Kim, 2011, Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases, J Korean Surg Soc, 81, 25, 10.4174/jkss.2011.81.1.25

Ko, 2014, Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases, World J Gastroenterol, 20, 525, 10.3748/wjg.v20.i2.525

Lee, 2012, Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer, Korean J Gastroenterol Taehan Sohwagi Hakhoe chi, 59, 218, 10.4166/kjg.2012.59.3.218

Lee, 2008, Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis, J Clin Gastroenterol, 42, 945, 10.1097/MCG.0b013e318064e752

McKay, 2009, Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases, HPB Surg, 2009, 346863, 10.1155/2009/346863

Nishiwada, 2014, Comparison between percutaneous radiofrequency ablation and surgical hepatectomy focusing on local disease control rate for colorectal liver metastases, HPB, 61, 436

Oshowo, 2003, Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases, Br J Surg, 90, 1240, 10.1002/bjs.4264

Otto, 2010, Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery, Ann Surg, 251, 796, 10.1097/SLA.0b013e3181bc9fae

Park, 2008, Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery, Ann Surg Oncol, 15, 227, 10.1245/s10434-007-9625-z

Reuter, 2009, Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?, J Gastrointest Surg, 13, 486, 10.1007/s11605-008-0727-0

White, 2007, Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis, J Gastrointest Surg Off J Soc Surg Aliment Tract, 11, 256, 10.1007/s11605-007-0100-8

Kopetz, 2009, Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy, J Clin Oncol Off J Am Soc Clin Oncol, 27, 3677, 10.1200/JCO.2008.20.5278

Brouquet, 2011, High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome, J Clin Oncol Off J Am Soc Clin Oncol, 29, 1083, 10.1200/JCO.2010.32.6132

de Ridder, 2016, Management of liver metastases in colorectal cancer patients: a retrospective case-control study of systemic therapy versus liver resection, Eur J Cancer, 59, 13, 10.1016/j.ejca.2016.02.003

Gillams, 2005, The use of radiofrequency in cancer, Br J Cancer, 92, 1825, 10.1038/sj.bjc.6602582

Wong, 2013, Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results, HPB, 15, 595, 10.1111/hpb.12014

Berber, 2008, Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors, Ann Surg Oncol, 15, 2757, 10.1245/s10434-008-0043-7

Ierardi, 2013, Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation, La Radiol Med, 118, 949, 10.1007/s11547-013-0968-1

Sietses, 2010, The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases, Surg Endosc, 24, 1917, 10.1007/s00464-009-0874-8

Nielsen, 2013, Incidence and treatment of local site recurrences following RFA of colorectal liver metastases, World J Surg, 37, 1340, 10.1007/s00268-013-1997-6

Nordlinger, 2013, Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial, Lancet Oncol, 14, 1208, 10.1016/S1470-2045(13)70447-9

t Lam-Boer, 2015, Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, 41, 1217

t Lam-Boer, 2017, Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in The Netherlands, Eur J Cancer, 71, 109, 10.1016/j.ejca.2016.10.026

Ruers, 2012, Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004), Ann Oncol Off J Eur Soc Med Oncol, 23, 2619, 10.1093/annonc/mds053